ACTOFERRIN PREVENTION OF NEONATAL SEPSIS

Not Applicable

• Registration Number: PER-113-11
• Lead Sponsor: IVERSIDAD PERUANA CAYETANO HEREDIA,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-12-27
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 414

Inclusion Criteria

1.NEONATES WITH BIRTH WEIGHT BETWEEN 500G and 2000G AT BIRTH TIME.
2. NEONATES BORN IN OR REFERRED TO, THE INTENSIVE OR INTERMEDIATE CARE UNIT OF NEONATOLOGY OF PARTICIPATING HOSPITALS BEFORE MENTIONED, IN THE FIRST 72 HOURS OF LIFE.

Exclusion Criteria

1. NEONATES WITH UNDERLYING GASTROINTESTINAL PROBLEMS THAT MAKES IMPOSSIBLE ORAL ROUTE.
2. NEONATES WITH UNDERLYING CONDITIONS DEEPLY AFFECTING GROWTH AND DEVELOPMENT (CHROMOSOMAL ABNORMALITIES, STRUCTURAL BRAIN ABNORMALITIES, SEVERE CONGENITAL ABNORMALITIES).
3. NEONATES WITH A FAMILIAR HISTORY OF ALLERGY TO COW´S MILK.
4. ANY NEONATE THAT IN AGREEMENT WITH THE RESEARCHER´S CRITERIA DON´T HAVE THE POSSIBILITY TO COMPLETE THE STUDY MONITORING VISITS (PATIENT THAT BEFORE TWO MONTHS OF AGE MUST RETURN TO PROVINCE).
5. NEONATES WHOSE PARENTS DO NOT WANT TO PARTICIPATE.

Study & Design

• Study Type: Interventional
• Study Design: Not specified